D18. Risk of Breast Cancer-Related Lymphedema: Development and Validation of a Clinically-Relevant, Patient-facing Prediction Model

• Danielle H. Rochlin, MD,
• Andrea V. Barrio, MD,
• Sarah A. McLaughlin, MD,
• Kimberly J. Van Zee, MD,
• Michelle R. Coriddi, MD,
• Joseph H. Dayan, MD MBA,
• Babak J. Mehrara, MD

Affiliations

Danielle H. Rochlin, MD

1 Memorial Sloan Kettering Cancer Center, New York, NY, USA

Andrea V. Barrio, MD

1 Memorial Sloan Kettering Cancer Center, New York, NY, USA

Sarah A. McLaughlin, MD

2 Mayo Clinic Florida, Jacksonville, FL, USA.

Kimberly J. Van Zee, MD

1 Memorial Sloan Kettering Cancer Center, New York, NY, USA

Michelle R. Coriddi, MD

1 Memorial Sloan Kettering Cancer Center, New York, NY, USA

Joseph H. Dayan, MD MBA

1 Memorial Sloan Kettering Cancer Center, New York, NY, USA

Babak J. Mehrara, MD

1 Memorial Sloan Kettering Cancer Center, New York, NY, USA